Literature DB >> 1325116

5'-Aminolevulinate synthase activity is decreased in skeletal muscle of anemic rats.

L A McNabney1, D A Essig.   

Abstract

Expression of the rate-limiting heme biosynthetic enzyme 5'-aminolevulinate synthase (ALAS) was investigated in skeletal muscle of 3-wk-old rats fed an iron-deficient diet. After 14 days, ALAS activity had declined 70% relative to control (2.1 +/- 0.2 vs. 0.6 +/- 0.1 nmol.h-1.g-1; P less than 0.005). Similar decreases were observed for blood hemoglobin (11.4 +/- 0.2 vs. 3.9 +/- 0.3 g/dl; P less than 0.005) and muscle cytochrome c (14.5 +/- 1.3 vs. 7.1 +/- 0.6 nmol/g; P less than 0.005). An iron-deficient diet decreased body and skeletal muscle growth by 15 (P less than 0.005) and 10% (P less than 0.05), respectively, whereas concentrations of protein, RNA, ALAS mRNA, and citrate synthase activity in muscle were not different from control. One mechanism by which heme biosynthesis may be slowed in muscle of young anemic rats is a decrease in ALAS activity. At a time when enzyme activity was decreased, ALAS mRNA expression was not affected by an iron-deficient diet, suggesting that steps after transcription of the ALAS gene may regulate the decrease in activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325116     DOI: 10.1152/ajpcell.1992.263.2.C429

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Delta-aminolevulinate synthase 2 polymorphism is associated with maximal oxygen uptake after Living-high exercise-high training-low in a male Chinese population.

Authors:  Yali Xu; Yang Hu; Zhijun Ren; Longyan Yi
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Testosterone plus low-intensity physical training in late life improves functional performance, skeletal muscle mitochondrial biogenesis, and mitochondrial quality control in male mice.

Authors:  Wen Guo; Siu Wong; Michelle Li; Wentao Liang; Marc Liesa; Carlo Serra; Ravi Jasuja; Andrzej Bartke; James L Kirkland; Orian Shirihai; Shalender Bhasin
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.